LGALS4 and Alzheimer disease: To investigate the effects of kefir peptidic fraction < 10 kDa treatment on the AD-like model (GMR-Gal4/+; UAS-Aβ/+), we initially evaluated the external structure of the eye (organization of ommatidia) in adult AD-model flies treated with and without peptide fraction.